Gene editing may replace lifelong meds but long-term safety remains a concern

ScienceDaily Health reported that advances in gene editing could enable a single treatment to protect against heart disease, high cholesterol, and other common conditions for decades, potentially replacing the need for daily medications.

Gene therapy currently treats some serious illnesses by introducing working gene copies, silencing harmful genes, or directly editing DNA. Unlike conventional drugs requiring repeated doses, some gene therapies aim to work after just one administration.

Researchers are investigating whether gene editing can manage widespread health problems such as obesity, diabetes, and cardiovascular diseases, expanding beyond rare genetic disorders where gene therapy has already seen success.

However, scientists caution that permanently altering genes carries risks that may only become apparent over years, making long-term safety a critical challenge before these therapies can be widely used.

Cardiologists from the University of Michigan Health Frankel Cardiovascular Center emphasized the need to carefully weigh the benefits of genomic therapies against their potential risks, highlighting the importance of thorough evaluation before offering these treatments to millions.